Stem Cell Reviews and Reports

, Volume 7, Issue 2, pp 269–291 | Cite as

The Potential of Adipose Stem Cells in Regenerative Medicine

  • Bettina Lindroos
  • Riitta Suuronen
  • Susanna Miettinen
Article

Abstract

Adipose stem cells (ASCs) are an attractive and abundant stem cell source with therapeutic applicability in diverse fields for the repair and regeneration of acute and chronically damaged tissues. Importantly, unlike the human bone marrow stromal/stem stem cells (BMSCs) that are present at low frequency in the bone marrow, ASCs can be retrieved in high number from either liposuction aspirates or subcutaneous adipose tissue fragments and can easily be expanded in vitro. ASCs display properties similar to that observed in BMSCs and, upon induction, undergo at least osteogenic, chondrogenic, adipogenic and neurogenic, differentiation in vitro. Furthermore, ASCs have been shown to be immunoprivileged, prevent severe graft-versus-host disease in vitro and in vivo and to be genetically stable in long-term culture. They have also proven applicability in other functions, such as providing hematopoietic support and gene transfer. Due to these characteristics, ASCs have rapidly advanced into clinical trials for treatment of a broad range of conditions. As cell therapies are becoming more frequent, clinical laboratories following good manufacturing practices are needed. At the same time as laboratory processes become more extensive, the need for control in the processing laboratory grows consequently involving a greater risk of complications and possibly adverse events for the recipient. Therefore, the safety, reproducibility and quality of the stem cells must thoroughly be examined prior to extensive use in clinical applications. In this review, some of the aspects of examination on ASCs in vitro and the utilization of ASCs in clinical studies are discussed.

Keywords

Adipose stem cells Stem cell therapy Good manufacturing practice Defined serum-free culturing conditions Flow cytometry 

References

  1. 1.
    Pittenger, M. F., Mackay, A. M., Beck, S. C., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143–147.PubMedGoogle Scholar
  2. 2.
    Gimble, J., & Guilak, F. (2003). Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy, 5, 362–369.PubMedGoogle Scholar
  3. 3.
    Bongso, A., Fong, C. Y., Ng, S. C., et al. (1994). Isolation and culture of inner cell mass cells from human blastocysts. Human Reproduction, 9, 2110–2117.PubMedGoogle Scholar
  4. 4.
    Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282, 1145–1147.PubMedGoogle Scholar
  5. 5.
    Yamanaka, S. (2008). Pluripotency and nuclear reprogramming. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 363, 2079–2087.PubMedGoogle Scholar
  6. 6.
    Amabile, G., & Meissner, A. (2009). Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends in Molecular Medicine, 15, 59–68.PubMedGoogle Scholar
  7. 7.
    Cyranoski, D. (2008). Stem cells: 5 things to know before jumping on the iPS bandwagon. Nature, 452, 406–408.PubMedGoogle Scholar
  8. 8.
    Friedenstein, A. J., Petrakova, K. V., Kurolesova, A. I., et al. (1968). Heterotopic of bone marrow.Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation, 6, 230–247.PubMedGoogle Scholar
  9. 9.
    Jaiswal, R. K., Jaiswal, N., Bruder, S. P., et al. (2000). Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. The Journal of Biological Chemistry, 275, 9645–9652.PubMedGoogle Scholar
  10. 10.
    Johnstone, B., Hering, T. M., Caplan, A. I., et al. (1998). In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Experimental Cell Research, 238, 265–272.PubMedGoogle Scholar
  11. 11.
    Zuk, P. A. (2008). Tissue engineering craniofacial defects with adult stem cells? Are we ready yet? Pediatric Research, 63, 478–486.PubMedGoogle Scholar
  12. 12.
    Zuk, P. A., Zhu, M., Mizuno, H., et al. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Engineering, 7, 211–228.PubMedGoogle Scholar
  13. 13.
    Zuk, P. A., Zhu, M., Ashjian, P., et al. (2002). Human adipose tissue is a source of multipotent stem cells. Molecular Biology of the Cell, 13, 4279–4295.PubMedGoogle Scholar
  14. 14.
    Gimble, J. M., Katz, A. J., & Bunnell, B. A. (2007). Adipose-derived stem cells for regenerative medicine. Circulation Research, 100, 1249–1260.PubMedGoogle Scholar
  15. 15.
    Planat-Benard, V., Silvestre, J. S., Cousin, B., et al. (2004). Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation, 109, 656–663.PubMedGoogle Scholar
  16. 16.
    Safford, K. M., Hicok, K. C., Safford, S. D., et al. (2002). Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochemical and Biophysical Research Communications, 294, 371–379.PubMedGoogle Scholar
  17. 17.
    Seo, M. J., Suh, S. Y., Bae, Y. C., et al. (2005). Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochemical and Biophysical Research Communications, 328, 258–264.PubMedGoogle Scholar
  18. 18.
    Timper, K., Seboek, D., Eberhardt, M., et al. (2006). Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochemical and Biophysical Research Communications, 341, 1135–1140.PubMedGoogle Scholar
  19. 19.
    Winter, A., Breit, S., Parsch, D., et al. (2003). Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis and Rheumatism, 48, 418–429.PubMedGoogle Scholar
  20. 20.
    Gonzalez-Rey, E., Gonzalez, M. A., Varela, N., et al. (2010). Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Annals of the Rheumatic Diseases, 69, 241–248.PubMedGoogle Scholar
  21. 21.
    Gonzalez-Rey, E., Anderson, P., Gonzalez, M. A., et al. (2009). Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut, 58, 929–939.PubMedGoogle Scholar
  22. 22.
    Meza-Zepeda, L. A., Noer, A., Dahl, J. A., et al. (2008). High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence. Journal of Cellular and Molecular Medicine, 12, 553–563.PubMedGoogle Scholar
  23. 23.
    Dahl, J. A., Duggal, S., Coulston, N., et al. (2008). Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum. The International Journal of Developmental Biology, 52, 1033–1042.PubMedGoogle Scholar
  24. 24.
    Fang, B., Song, Y., Liao, L., et al. (2007). Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease. Transplantation Proceedings, 39, 3358–3362.PubMedGoogle Scholar
  25. 25.
    Fang, B., Song, Y., Lin, Q., et al. (2007). Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children. Pediatric Transplantation, 11, 814–817.PubMedGoogle Scholar
  26. 26.
    Fang, B., Song, Y., Zhao, R. C., et al. (2007). Using human adipose tissue-derived mesenchymal stem cells as salvage therapy for hepatic graft-versus-host disease resembling acute hepatitis. Transplantation Proceedings, 39, 1710–1713.PubMedGoogle Scholar
  27. 27.
    Fang, B., Song, Y. P., Liao, L. M., et al. (2006). Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells. Bone Marrow Transplantation, 38, 389–390.PubMedGoogle Scholar
  28. 28.
    Garcia-Olmo, D., Garcia-Arranz, M., & Herreros, D. (2008). Expanded adipose-derived stem cells for the treatment of complex perianal fistula including Crohn’s disease. Expert Opinion on Biological Therapy, 8, 1417–1423.PubMedGoogle Scholar
  29. 29.
    Riordan, N. H., Ichim, T. E., Min, W. P., et al. (2009). Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. Journal of Translational Medicine, 7, 29.PubMedGoogle Scholar
  30. 30.
    Yoshimura, K., Sato, K., Aoi, N., et al. (2008). Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plastic Surgery, 32, 48–55. discussion 56–47.PubMedGoogle Scholar
  31. 31.
    Yoshimura, K., Sato, K., Aoi, N., et al. (2008). Cell-assisted lipotransfer for facial lipoatrophy: efficacy of clinical use of adipose-derived stem cells. Dermatologic Surgery, 34, 1178–1185.PubMedGoogle Scholar
  32. 32.
    Lendeckel, S., Jodicke, A., Christophis, P., et al. (2004). Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. Journal of Craniomaxillofacial Surgery, 32, 370–373.Google Scholar
  33. 33.
    Mesimäki, K., Lindroos, B., Törnwall, J., et al. (2009). Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. International Journal of Oral and Maxillofacial Surgery, 38, 201–209.PubMedGoogle Scholar
  34. 34.
    Becker, A. J., McCulloch, E. A., & Till, J. E. (1963). Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature, 197, 452–454.PubMedGoogle Scholar
  35. 35.
    Orkin, S. H. (2000). Diversification of haematopoietic stem cells to specific lineages. Nature Reviews. Genetics, 1, 57–64.PubMedGoogle Scholar
  36. 36.
    Lagasse, E., Connors, H., Al-Dhalimy, M., et al. (2000). Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Natural Medicines, 6, 1229–1234.Google Scholar
  37. 37.
    Piersma, A. H., Brockbank, K. G., Ploemacher, R. E., et al. (1985). Characterization of fibroblastic stromal cells from murine bone marrow. Experimental Hematology, 13, 237–243.PubMedGoogle Scholar
  38. 38.
    Owen, M. (1988). Marrow stromal stem cells. Journal of Cell Science Supplement, 10, 63–76.PubMedGoogle Scholar
  39. 39.
    Caplan, A. I. (1991). Mesenchymal stem cells. Journal of Orthopaedic Research, 9, 641–650.PubMedGoogle Scholar
  40. 40.
    Pereira, R. F., Halford, K. W., O’Hara, M. D., et al. (1995). Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proceedings of the National Academy of Sciences of the United States of America, 92, 4857–4861.PubMedGoogle Scholar
  41. 41.
    Pereira, R. F., O’Hara, M. D., Laptev, A. V., et al. (1998). Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proceedings of the National Academy of Sciences of the United States of America, 95, 1142–1147.PubMedGoogle Scholar
  42. 42.
    Horwitz, E. M., Gordon, P. L., Koo, W. K., et al. (2002). Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proceedings of the National Academy of Sciences of the United States of America, 99, 8932–8937.PubMedGoogle Scholar
  43. 43.
    Horwitz, E. M., Prockop, D. J., Fitzpatrick, L. A., et al. (1999). Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Natural Medicines, 5, 309–313.Google Scholar
  44. 44.
    Horwitz, E. M., Prockop, D. J., Gordon, P. L., et al. (2001). Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood, 97, 1227–1231.PubMedGoogle Scholar
  45. 45.
    Keating, A., Berkahn, L., & Filshie, R. (1998). A Phase I study of the transplantation of genetically marked autologous bone marrow stromal cells. Human Gene Therapy, 9, 591–600.PubMedGoogle Scholar
  46. 46.
    Dominici, M., Le Blanc, K., Mueller, I., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8, 315–317.PubMedGoogle Scholar
  47. 47.
    Horwitz, E. M., Le Blanc, K., Dominici, M., et al. (2005). Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy, 7, 393–395.PubMedGoogle Scholar
  48. 48.
    Caplan, A. I., & Bruder, S. P. (2001). Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends in Molecular Medicine, 7, 259–264.PubMedGoogle Scholar
  49. 49.
    Brinchmann, J. E. (2008). Expanding autologous multipotent mesenchymal bone marrow stromal cells. Journal of the Neurological Sciences, 265, 127–130.PubMedGoogle Scholar
  50. 50.
    Lindroos, B., Mäenpää, K., Ylikomi, T., et al. (2008). Characterisation of human dental stem cells and buccal mucosa fibroblasts. Biochemical and Biophysical Research Communications, 368, 329–335.PubMedGoogle Scholar
  51. 51.
    Grace, W., Gerold, S., Friedrich, H., et al. (2000). Stem Cell Plasticity in Mammals and Transdetermination in Drosophila: common themes? Stem Cells, 18, 409–414.Google Scholar
  52. 52.
    Donald, G. P., & Darwin, J. P. (2007). Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair - current views. Stem Cells, 25, 2896–2902.Google Scholar
  53. 53.
    Kahn, A. J., & Simmons, D. J. (1977). Chondrocyte-to-osteocyte transformation in grafts of perichondrium-free epiphyseal cartilage. Clinical Orthopaedics and Related Research 299–304.Google Scholar
  54. 54.
    Bennett, J. H., Joyner, C. J., Triffitt, J. T., et al. (1991). Adipocytic cells cultured from marrow have osteogenic potential. Journal of Cell Science, 99, 131–139.PubMedGoogle Scholar
  55. 55.
    Rada, T., Reis, R. L., & Gomes, M. E. (2009). Adipose tissue-derived stem cells and their application in bone and cartilage tissue engineering. Tissue Engineering. Part B: Reviews, 15, 113–125.Google Scholar
  56. 56.
    Huang, J. I., Zuk, P. A., Jones, N. F., et al. (2004). Chondrogenic potential of multipotential cells from human adipose tissue. Plastic and Reconstructive Surgery, 113, 585–594.PubMedGoogle Scholar
  57. 57.
    Daher, S. R., Johnstone, B. H., Phinney, D. G., et al. (2008). Adipose stromal/stem cells: basic and translational advances: the IFATS collection. Stem Cells, 26, 2664–2665.PubMedGoogle Scholar
  58. 58.
    Fraser, J. K., Wulur, I., Alfonso, Z., et al. (2006). Fat tissue: an underappreciated source of stem cells for biotechnology. Trends in Biotechnology, 24, 150–154.PubMedGoogle Scholar
  59. 59.
    Strem, B. M., Hicok, K. C., Zhu, M., et al. (2005). Multipotential differentiation of adipose tissue-derived stem cells. The Keio Journal of Medicine, 54, 132–141.PubMedGoogle Scholar
  60. 60.
    Tremolada, C., Palmieri, G., & Ricordi, C. Adipocyte transplantation and stem cells: plastic surgery meets regenerative medicine. Cell Transplantation Google Scholar
  61. 61.
    Lin, K., Matsubara, Y., Masuda, Y., et al. (2008). Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy, 10, 417–426.PubMedGoogle Scholar
  62. 62.
    Lin, K., Matsubara, Y., Masuda, Y., et al. (2008). Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy, 10, 417–426.PubMedGoogle Scholar
  63. 63.
    Yamamoto, T., Gotoh, M., Hattori, R., et al. Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy: report of two initial cases. International Journal of Urology Urol 17, 75–82.Google Scholar
  64. 64.
    Duckers, H. J., Pinkernell, K., Milstein, A. M., et al. (2006). The bedside celution system for isolation of adipose derived regenerative cells. EuroIntervention, 2, 395–398.PubMedGoogle Scholar
  65. 65.
    Tissue Genesis Cell Isolation System. Tissue Genesis Incorporated. February 10th, 2009. Available at: http://www.tissuegenesis.com/.
  66. 66.
    Cytori’s Celution® 700 System to be Regulated as a Medical Device by U.S. FDA. 20 Jul 2009. Available at: http://www.medicalnewstoday.com/articles/158091.php.
  67. 67.
    Fraser, J. K., Wulur, I., Alfonso, Z., et al. (2007). Differences in stem and progenitor cell yield in different subcutaneous adipose tissue depots. Cytotherapy, 9, 459–467.PubMedGoogle Scholar
  68. 68.
    Oedayrajsingh-Varma, M. J., van Ham, S. M., Knippenberg, M., et al. (2006). Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy, 8, 166–177.PubMedGoogle Scholar
  69. 69.
    Jurgens, W. J., Oedayrajsingh-Varma, M. J., Helder, M. N., et al. (2008). Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cell-based therapies. Cell and Tissue Research, 332, 415–426.PubMedGoogle Scholar
  70. 70.
    von Heimburg, D., Hemmrich, K., Haydarlioglu, S., et al. (2004). Comparison of viable cell yield from excised versus aspirated adipose tissue. Cells, Tissues, Organs, 178, 87–92.Google Scholar
  71. 71.
    Rodbell, M. (1964). Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. The Journal of Biological Chemistry, 239, 375–380.PubMedGoogle Scholar
  72. 72.
    Katz, A. J., Llull, R., Hedrick, M. H., et al. (1999). Emerging approaches to the tissue engineering of fat. Clinics in Plastic Surgery, 26, 587–603. viii.PubMedGoogle Scholar
  73. 73.
    Katz, A. J., Tholpady, A., Tholpady, S. S., et al. (2005). Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells, 23, 412–423.PubMedGoogle Scholar
  74. 74.
    Katz, A. J., Hedrick, M. H., Llull, R., et al. (2001). A novel device for the simple and efficient refinement of liposuctioned tissue. Plastic and Reconstructive Surgery, 107, 595–597.PubMedGoogle Scholar
  75. 75.
    Gronthos, S., Franklin, D. M., Leddy, H. A., et al. (2001). Surface protein characterization of human adipose tissue-derived stromal cells. Journal of Cellular Physiology, 189, 54–63.PubMedGoogle Scholar
  76. 76.
    Boquest, A. C., Shahdadfar, A., Brinchmann, J. E., et al. (2006). Isolation of stromal stem cells from human adipose tissue. Methods in Molecular Biology, 325, 35–46.PubMedGoogle Scholar
  77. 77.
    Simmons, P. J., & Torok-Storb, B. (1991). Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood, 78, 55–62.PubMedGoogle Scholar
  78. 78.
    Quirici, N., Soligo, D., Bossolasco, P., et al. (2002). Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Experimental Hematology, 30, 783–791.PubMedGoogle Scholar
  79. 79.
    Gronthos, S., Fitter, S., Diamond, P., et al. (2007). A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells. Stem Cells and Development, 16, 953–963.PubMedGoogle Scholar
  80. 80.
    Battula, V. L., Treml, S., Bareiss, P. M., et al. (2009). Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica, 94, 173–184.PubMedGoogle Scholar
  81. 81.
    Tapp, H., Hanley, E. N., Jr., Patt, J. C., et al. (2009). Adipose-derived stem cells: characterization and current application in orthopaedic tissue repair. Experimental Biology and Medicine (Maywood), 234, 1–9.Google Scholar
  82. 82.
    Garcia-Castro, J., Trigueros, C., Madrenas, J., et al. (2008). Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. Journal of Cellular and Molecular Medicine, 12, 2552–2565.PubMedGoogle Scholar
  83. 83.
    De Ugarte, D. A., Alfonso, Z., Zuk, P. A., et al. (2003). Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunology Letters, 89, 267–270.PubMedGoogle Scholar
  84. 84.
    McIntosh, K., Zvonic, S., Garrett, S., et al. (2006). The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells, 24, 1246–1253.PubMedGoogle Scholar
  85. 85.
    Mitchell, J. B., McIntosh, K., Zvonic, S., et al. (2006). Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells, 24, 376–385.PubMedGoogle Scholar
  86. 86.
    Simmons, P. J., Masinovsky, B., Longenecker, B. M., et al. (1992). Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood, 80, 388–395.PubMedGoogle Scholar
  87. 87.
    Sudhoff, T., & Sohngen, D. (2002). Circulating endothelial adhesion molecules (sE-selectin, sVCAM-1 and sICAM-1) during rHuG-CSF-stimulated stem cell mobilization. Journal of Hematotherapy & Stem Cell Research, 11, 147–151.Google Scholar
  88. 88.
    Otto, T. C., & Lane, M. D. (2005). Adipose development: from stem cell to adipocyte. Critical Reviews in Biochemistry and Molecular Biology, 40, 229–242.PubMedGoogle Scholar
  89. 89.
    Deslex, S., Negrel, R., Vannier, C., et al. (1987). Differentiation of human adipocyte precursors in a chemically defined serum-free medium. International Journal of Obesity, 11, 19–27.PubMedGoogle Scholar
  90. 90.
    Hauner, H., Entenmann, G., Wabitsch, M., et al. (1989). Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. Journal of Clinical Investigation, 84, 1663–1670.PubMedGoogle Scholar
  91. 91.
    Sen, A., Lea-Currie, Y. R., Sujkowska, D., et al. (2001). Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. Journal of Cellular Biochemistry, 81, 312–319.PubMedGoogle Scholar
  92. 92.
    Christodoulides, C., Lagathu, C., Sethi, J. K., et al. (2009). Adipogenesis and WNT signalling. Trends in Endocrinology and Metabolism, 20, 16–24.PubMedGoogle Scholar
  93. 93.
    Moldes, M., Zuo, Y., Morrison, R. F., et al. (2003). Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. The Biochemical Journal, 376, 607–613.PubMedGoogle Scholar
  94. 94.
    Won Park, K., Halperin, D. S., & Tontonoz, P. (2008). Before they were fat: adipocyte progenitors. Cell Metabolism, 8, 454–457.Google Scholar
  95. 95.
    Gregoire, F. M., Smas, C. M., & Sul, H. S. (1998). Understanding adipocyte differentiation. Physiological Reviews, 78, 783–809.PubMedGoogle Scholar
  96. 96.
    Gimble, J. M., Morgan, C., Kelly, K., et al. (1995). Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells. Journal of Cellular Biochemistry, 58, 393–402.PubMedGoogle Scholar
  97. 97.
    Lindroos, B., Aho, K.-L., Kuokkanen, H., et al. (2010). Differential gene expression in adipose stem cells cultured in allogeneic human serum versus fetal bovine serum. Tissue Engineering Part A, 16, 2281–2294.PubMedGoogle Scholar
  98. 98.
    Lindroos, B., Boucher, S., Chase, L., et al. (2009). Serum-free, xeno-free culture media maintain the proliferation rate and multipotentiality of adipose stem cells in vitro. Cytotherapy, 11, 958–972.PubMedGoogle Scholar
  99. 99.
    Rajala, K., Lindroos, B., Hussein, S. M., et al. A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells. PLoS One, 5, e10246.Google Scholar
  100. 100.
    Zhou, S., Eid, K., & Glowacki, J. (2004). Cooperation between TGF-beta and Wnt pathways during chondrocyte and adipocyte differentiation of human marrow stromal cells. Journal of Bone and Mineral Research, 19, 463–470.PubMedGoogle Scholar
  101. 101.
    Takada, I., Kouzmenko, A. P., & Kato, S. (2009). Molecular switching of osteoblastogenesis versus adipogenesis: implications for targeted therapies. Expert Opinion on Therapeutic Targets, 13, 593–603.PubMedGoogle Scholar
  102. 102.
    Aubin, J. E., Liu, F., Malaval, L., et al. (1995). Osteoblast and chondroblast differentiation. Bone, 17, 77S–83S.PubMedGoogle Scholar
  103. 103.
    Liu, T. M., Martina, M., Hutmacher, D. W., et al. (2007). Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells, 25, 750–760.PubMedGoogle Scholar
  104. 104.
    Aubin, J. E. (2001). Regulation of osteoblast formation and function. Reviews in Endocrine & Metabolic Disorders, 2, 81–94.Google Scholar
  105. 105.
    Madras, N., Gibbs, A. L., Zhou, Y., et al. (2002). Modeling stem cell development by retrospective analysis of gene expression profiles in single progenitor-derived colonies. Stem Cells, 20, 230–240.PubMedGoogle Scholar
  106. 106.
    Halvorsen, Y. D., Franklin, D., Bond, A. L., et al. (2001). Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Engineering, 7, 729–741.PubMedGoogle Scholar
  107. 107.
    Halvorsen, Y. C., Wilkison, W. O., & Gimble, J. M. (2000). Adipose-derived stromal cells–their utility and potential in bone formation. International Journal of Obesity and Related Metabolic Disorders, 24(Suppl 4), S41–S44.PubMedGoogle Scholar
  108. 108.
    Aksu, A. E., Rubin, J. P., Dudas, J. R., et al. (2008). Role of gender and anatomical region on induction of osteogenic differentiation of human adipose-derived stem cells. Annals of Plastic Surgery, 60, 306–322.PubMedGoogle Scholar
  109. 109.
    Zhu, M., Kohan, E., Bradley, J., et al. (2009). The effect of age on osteogenic, adipogenic and proliferative potential of female adipose-derived stem cells. Journal of Tissue Engineering and Regenerative Medicine, 3, 290–301.PubMedGoogle Scholar
  110. 110.
    Denker, A. E., Nicoll, S. B., & Tuan, R. S. (1995). Formation of cartilage-like spheroids by micromass cultures of murine C3H10T1/2 cells upon treatment with transforming growth factor-beta 1. Differentiation, 59, 25–34.PubMedGoogle Scholar
  111. 111.
    Wei, Y., Sun, X., Wang, W., et al. (2007). Adipose-derived stem cells and chondrogenesis. Cytotherapy, 9, 712–716.PubMedGoogle Scholar
  112. 112.
    Awad, H. A., Wickham, M. Q., Leddy, H. A., et al. (2004). Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials, 25, 3211–3222.PubMedGoogle Scholar
  113. 113.
    Knippenberg, M., Helder, M. N., Zandieh Doulabi, B., et al. (2006). Osteogenesis versus chondrogenesis by BMP-2 and BMP-7 in adipose stem cells. Biochemical and Biophysical Research Communications, 342, 902–908.PubMedGoogle Scholar
  114. 114.
    Diekman, B. O., Estes, B. T., & Guilak, F. (2010). The effects of BMP6 overexpression on adipose stem cell chondrogenesis: Interactions with dexamethasone and exogenous growth factors. Journal of Biomedical Materials Research Part A, 93A, 994–1003.Google Scholar
  115. 115.
    Estes, B. T., Wu, A. W., & Guilak, F. (2006). Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6. Arthritis and Rheumatism, 54, 1222–1232.PubMedGoogle Scholar
  116. 116.
    Erickson, G. R., Gimble, J. M., Franklin, D. M., et al. (2002). Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochemical and Biophysical Research Communications, 290, 763–769.PubMedGoogle Scholar
  117. 117.
    Koga, H., Engebretsen, L., Brinchmann, J. E., et al. (2009). Mesenchymal stem cell-based therapy for cartilage repair: a review. Knee Surgery, Sports Traumatology, Arthroscopy.Google Scholar
  118. 118.
    Huang, J. I., Kazmi, N., Durbhakula, M. M., et al. (2005). Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: a patient-matched comparison. Journal of Orthopaedic Research, 23, 1383–1389.PubMedGoogle Scholar
  119. 119.
    Im, G. I., Shin, Y. W., & Lee, K. B. (2005). Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis and Cartilage, 13, 845–853.PubMedGoogle Scholar
  120. 120.
    Kim, H. J., & Im, G. I. (2009). Chondrogenic differentiation of adipose tissue-derived mesenchymal stem cells: greater doses of growth factor are necessary. Journal of Orthopaedic Research, 27, 612–619.PubMedGoogle Scholar
  121. 121.
    van Dijk, A., Niessen, H. W., Zandieh Doulabi, B., et al. (2008). Differentiation of human adipose-derived stem cells towards cardiomyocytes is facilitated by laminin. Cell and Tissue Research, 334, 457–467.PubMedGoogle Scholar
  122. 122.
    Bai, X., Pinkernell, K., Song, Y. H., et al. (2007). Genetically selected stem cells from human adipose tissue express cardiac markers. Biochemical and Biophysical Research Communications, 353, 665–671.PubMedGoogle Scholar
  123. 123.
    Song, Y. H., Gehmert, S., Sadat, S., et al. (2007). VEGF is critical for spontaneous differentiation of stem cells into cardiomyocytes. Biochemical and Biophysical Research Communications, 354, 999–1003.PubMedGoogle Scholar
  124. 124.
    Valina, C., Pinkernell, K., Song, Y. H., et al. (2007). Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. European Heart Journal, 28, 2667–2677.PubMedGoogle Scholar
  125. 125.
    Mizuno, H., Zuk, P. A., Zhu, M., et al. (2002). Myogenic differentiation by human processed lipoaspirate cells. Plastic and Reconstructive Surgery, 109, 199–209. discussion 210–191.PubMedGoogle Scholar
  126. 126.
    Madonna, R., Geng, Y.-J., & De Caterina, R. (2009). Adipose tissue-derived stem cells: characterization and potential for cardiovascular repair. Arteriosclerosis, Thrombosis, and Vascular Biology, 29, 1723–1729.PubMedGoogle Scholar
  127. 127.
    Miranville, A., Heeschen, C., Sengenes, C., et al. (2004). Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation, 110, 349–355.PubMedGoogle Scholar
  128. 128.
    De Francesco, F., Tirino, V., Desiderio, V., et al. (2009). Human CD34+/CD90+ ASCs are capable of growing as sphere clusters, producing high levels of VEGF and forming capillaries. PLoS ONE, 4, e6537.PubMedGoogle Scholar
  129. 129.
    Boquest, A. C., Noer, A., Sorensen, A. L., et al. (2007). CpG methylation profiles of endothelial cell-specific gene promoter regions in adipose tissue stem cells suggest limited differentiation potential toward the endothelial cell lineage. Stem Cells, 25, 852–861.PubMedGoogle Scholar
  130. 130.
    Rehman, J., Traktuev, D., Li, J., et al. (2004). Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation, 109, 1292–1298.PubMedGoogle Scholar
  131. 131.
    Kim, S. C., Han, D. J., & Lee, J. Y. Adipose tissue derived stem cells for regeneration and differentiation into insulin-producing cells. Current Stem Cell Research and Therapy, 5, 190–194.Google Scholar
  132. 132.
    Lee, J., Han, D. J., & Kim, S. C. (2008). In vitro differentiation of human adipose tissue-derived stem cells into cells with pancreatic phenotype by regenerating pancreas extract. Biochemical and Biophysical Research Communications, 375, 547–551.PubMedGoogle Scholar
  133. 133.
    Kang, H. M., Kim, J., Park, S., et al. (2009). Insulin-secreting cells from human eyelid-derived stem cells alleviate type I diabetes in immunocompetent mice. Stem Cells, 27, 1999–2008.PubMedGoogle Scholar
  134. 134.
    Lin, G., Wang, G., Liu, G., et al. (2009). Treatment of type 1 diabetes with adipose tissue-derived stem cells expressing pancreatic duodenal homeobox 1. Stem Cells and Development, 18, 1399–1406.PubMedGoogle Scholar
  135. 135.
    Talens-Visconti, R., Bonora, A., Jover, R., et al. (2006). Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells. World Journal of Gastroenterology, 12, 5834–5845.PubMedGoogle Scholar
  136. 136.
    Dhar, S., Yoon, E. S., Kachgal, S., et al. (2007). Long-term maintenance of neuronally differentiated human adipose tissue-derived stem cells. Tissue Engineering, 13, 2625–2632.PubMedGoogle Scholar
  137. 137.
    Ashjian, P. H., Elbarbary, A. S., Edmonds, B., et al. (2003). In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plastic and Reconstructive Surgery, 111, 1922–1931.PubMedGoogle Scholar
  138. 138.
    Aluigi, M. G., Coradeghini, R., Guida, C., et al. (2009). Pre-adipocytes commitment to neurogenesis 1: preliminary localisation of cholinergic molecules. Cell Biology International, 33, 594–601.PubMedGoogle Scholar
  139. 139.
    Burger, S. R. (2000). Design and operation of a current good manufacturing practices cell-engineering laboratory. Cytotherapy, 2, 111–122.PubMedGoogle Scholar
  140. 140.
    Harvath, L. (2000). Food and Drug Administration’s proposed approach to regulation of hematopoietic stem/progenitor cell products for therapeutic use. Transfusion Medicine Reviews, 14, 104–111.PubMedGoogle Scholar
  141. 141.
    DIRECTIVE 2001/83/EC of the European Parliament and of the Council on the Community Code Relating to Medicinal Products for Human Use. The European Parliament and of the Council of the Community. Available at: http://www.emea.europa.eu/pdfs/human/pmf/2001-83-EC.pdf.
  142. 142.
    Guideline on Human Cell-Based Medicinal Products. EMEA, Committee for Human Medicinal Products. Available at: http://www.emea.europa.eu/pdfs/human/cpwp/41086906enfin.pdf.
  143. 143.
    Rehmann, W., Morgan, G. The Regulation of Advanced Therapies: Perspectives from the EU [Regulatory Feature]. February 2009. Available at: http://www.taylorwessing.com/uploads/tx_siruplawyermanagement/The_Regulation_of_Advanced_Therapies.pdf.
  144. 144.
    Halme, D. G., & Kessler, D. A. (2006). FDA regulation of stem-cell-based therapies. The New England Journal of Medicine, 355, 1730–1735.PubMedGoogle Scholar
  145. 145.
    Regulation (EC) no 1394/2007 of the European Parliament and of the Council. Official Journal of the European Union. Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2007:324:0121:0137:en:PDF.
  146. 146.
    Sensebé, L., Krampera, M., Schrezenmeier, H., et al. (2010). Mesenchymal stem cells for clinical application. Vox Sanguinis, 98, 93–107.PubMedGoogle Scholar
  147. 147.
    Kocaoemer, A., Kern, S., Kluter, H., et al. (2007). Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells, 25, 1270–1278.PubMedGoogle Scholar
  148. 148.
    Bieback, K., Hecker, A., Kocaomer, A., et al. (2009). Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells, 27, 2331–2341.PubMedGoogle Scholar
  149. 149.
    Herrera, B., & Inman, G. J. (2009). A rapid and sensitive bioassay for the simultaneous measurement of multiple bone morphogenetic proteins. Identification and quantification of BMP4, BMP6 and BMP9 in bovine and human serum. BMC Cell Biology, 10, 20.PubMedGoogle Scholar
  150. 150.
    Mirabet, V., Solves, P., Minana, M. D., et al. (2008). Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissues. Cell and Tissue Banking, 9, 1–10.PubMedGoogle Scholar
  151. 151.
    Muramatsu, T., Pinontoan, R., & Okumura, J. (1995). Biopotency of fetal bovine serum, and insulin and insulin-like growth factors I and II in enhancing whole-body protein synthesis of chicken embryos cultured in vitro. Comparative Biochemistry and Physiology. Part C: Pharmacology, Toxicology & Endocrinology, 111, 281–286.Google Scholar
  152. 152.
    Gstraunthaler, G. (2003). Alternatives to the use of fetal bovine serum: serum-free cell culture. Altex, 20, 275–281.PubMedGoogle Scholar
  153. 153.
    Katz, A. J., & Parker, A. M. (2006). Methods and Compositions for Growing Adipose Stem Cells, WO 2007/030652 A2:69.Google Scholar
  154. 154.
    Kim, S. J., Cho, H. H., Kim, Y. J., et al. (2005). Human adipose stromal cells expanded in human serum promote engraftment of human peripheral blood hematopoietic stem cells in NOD/SCID mice. Biochemical and Biophysical Research Communications, 329, 25–31.PubMedGoogle Scholar
  155. 155.
    Spees, J. L., Gregory, C. A., Singh, H., et al. (2004). Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Molecular Therapy, 9, 747–756.PubMedGoogle Scholar
  156. 156.
    Heiskanen, A., Satomaa, T., Tiitinen, S., et al. (2007). N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells, 25, 197–202.PubMedGoogle Scholar
  157. 157.
    Martin, M. J., Muotri, A., Gage, F., et al. (2005). Human embryonic stem cells express an immunogenic nonhuman sialic acid. Natural Medicines, 11, 228–232.Google Scholar
  158. 158.
    Mackensen, A., Drager, R., Schlesier, M., et al. (2000). Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunology, Immunotherapy, 49, 152–156.PubMedGoogle Scholar
  159. 159.
    Selvaggi, T. A., Walker, R. E., & Fleisher, T. A. (1997). Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood, 89, 776–779.PubMedGoogle Scholar
  160. 160.
    Will, R. G., Ironside, J. W., Zeidler, M., et al. (1996). A new variant of Creutzfeldt-Jakob disease in the UK. Lancet, 347, 921–925.PubMedGoogle Scholar
  161. 161.
    Stute, N., Holtz, K., Bubenheim, M., et al. (2004). Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Experimental Hematology, 32, 1212–1225.PubMedGoogle Scholar
  162. 162.
    Shahdadfar, A., Fronsdal, K., Haug, T., et al. (2005). In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells, 23, 1357–1366.PubMedGoogle Scholar
  163. 163.
    Shigeno, Y., & Ashton, B. A. (1995). Human bone-cell proliferation in vitro decreases with human donor age. The Journal of Bone and Joint Surgery British Volume, 77, 139–142.PubMedGoogle Scholar
  164. 164.
    Koller, M. R., Maher, R. J., Manchel, I., et al. (1998). Alternatives to animal sera for human bone marrow cell expansion: human serum and serum-free media. Journal of Hematotherapy, 7, 413–423.PubMedGoogle Scholar
  165. 165.
    Nimura, A., Muneta, T., Koga, H., et al. (2008). Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum. Arthritis and Rheumatism, 58, 501–510.PubMedGoogle Scholar
  166. 166.
    Anselme, K., Broux, O., Noel, B., et al. (2002). In vitro control of human bone marrow stromal cells for bone tissue engineering. Tissue Engineering, 8, 941–953.PubMedGoogle Scholar
  167. 167.
    Yamamoto, N., Isobe, M., Negishi, A., et al. (2003). Effects of autologous serum on osteoblastic differentiation in human bone marrow cells. Journal of Medical and Dental Sciences, 50, 63–69.PubMedGoogle Scholar
  168. 168.
    Oreffo, R. O., & Triffitt, J. T. (1999). Future potentials for using osteogenic stem cells and biomaterials in orthopedics. Bone, 25, 5S–9S.PubMedGoogle Scholar
  169. 169.
    Su, C. Y., Kuo, Y. P., Lin, Y. C., et al. (2009). A virally inactivated functional growth factor preparation from human platelet concentrates. Vox Sanguinis, 97, 119–128.PubMedGoogle Scholar
  170. 170.
    Luttun, A., Ross, J. J., Verfaillie, C., et al. (2006). Differentiation of multipotent adult progenitor cells into functional endothelial and smooth muscle cells. Curr Protoc Immunol; Chapter 22:Unit 22F 29.Google Scholar
  171. 171.
    Caterson, E. J., Nesti, L. J., Danielson, K. G., et al. (2002). Human marrow-derived mesenchymal progenitor cells: isolation, culture expansion, and analysis of differentiation. Molecular Biotechnology, 20, 245–256.PubMedGoogle Scholar
  172. 172.
    Parker, A. M., Shang, H., Khurgel, M., et al. (2007). Low serum and serum-free culture of multipotential human adipose stem cells. Cytotherapy, 9, 637–646.PubMedGoogle Scholar
  173. 173.
    Frechette, J. P., Martineau, I., & Gagnon, G. (2005). Platelet-rich plasmas: growth factor content and roles in wound healing. Journal of Dental Research, 84, 434–439.PubMedGoogle Scholar
  174. 174.
    Johansson, L., Klinth, J., Holmqvist, O., et al. (2003). Platelet lysate: a replacement for fetal bovine serum in animal cell culture? Cytotechnology, 42, 67–74.PubMedGoogle Scholar
  175. 175.
    Salvadé, A., Mina, P. D., Gaddi, D., et al. (2010). Characterization of platelet lysate cultured mesenchymal stromal cells and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects. Tissue Engineering. Part C: Methods, 16, 201–214.Google Scholar
  176. 176.
    Qizhou, L., Elias, L., Keng Suan, Y., et al. (2007). Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs. Stem Cells, 25, 425–436.Google Scholar
  177. 177.
    Meuleman, N., Tondreau, T., Delforge, A., et al. (2006). Human marrow mesenchymal stem cell culture: serum-free medium allows better expansion than classical alpha-MEM medium. European Journal of Haematology, 76, 309–316.PubMedGoogle Scholar
  178. 178.
    Izadpanah, R., Kaushal, D., Kriedt, C., et al. (2008). Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Research, 68, 4229–4238.PubMedGoogle Scholar
  179. 179.
    Boquest, A. C., Shahdadfar, A., Fronsdal, K., et al. (2005). Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Molecular Biology of the Cell, 16, 1131–1141.PubMedGoogle Scholar
  180. 180.
    Guilak, F. (2002). Functional tissue engineering: the role of biomechanics in reparative medicine. Annals of the New York Academy of Sciences, 961, 193–195.PubMedGoogle Scholar
  181. 181.
    Sundelacruz, S., & Kaplan, D. L. (2009). Stem cell- and scaffold-based tissue engineering approaches to osteochondral regenerative medicine. Seminars in Cell & Developmental Biology, 20, 646–655.Google Scholar
  182. 182.
    Le Blanc, K., Tammik, L., Sundberg, B., et al. (2003). Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scandinavian Journal of Immunology, 57, 11–20.PubMedGoogle Scholar
  183. 183.
    Bartholomew, A., Sturgeon, C., Siatskas, M., et al. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Experimental Hematology, 30, 42–48.PubMedGoogle Scholar
  184. 184.
    Tse, W. T., Pendleton, J. D., Beyer, W. M., et al. (2003). Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation, 75, 389–397.PubMedGoogle Scholar
  185. 185.
    Lazarus, H., Curtin, P., Devine, S., et al. (2000). Role of mesenchymal stem cells (MSC) in allogeneic transplantation: Early phase I clinical results. Blood, 96, 1691.Google Scholar
  186. 186.
    Jorgensen, C., Djouad, F., Apparailly, F., et al. (2003). Engineering mesenchymal stem cells for immunotherapy. Gene Therapy, 10, 928–931.PubMedGoogle Scholar
  187. 187.
    Aust, L., Devlin, B., Foster, S. J., et al. (2004). Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy, 6, 7–14.PubMedGoogle Scholar
  188. 188.
    Cui, L., Yin, S., Liu, W., et al. (2007). Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Engineering, 13, 1185–1195.PubMedGoogle Scholar
  189. 189.
    Puissant, B., Barreau, C., Bourin, P., et al. (2005). Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. British Journal Haematology, 129, 118–129.Google Scholar
  190. 190.
    Niemeyer, P., Vohrer, J., Schmal, H., et al. (2008). Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice. Cytotherapy, 10, 784–795.PubMedGoogle Scholar
  191. 191.
    Yanez, R., Lamana, M. L., Garcia-Castro, J., et al. (2006). Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells, 24, 2582–2591.PubMedGoogle Scholar
  192. 192.
    Kucerova, L., Altanerova, V., Matuskova, M., et al. (2007). Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Research, 67, 6304–6313.PubMedGoogle Scholar
  193. 193.
    Yu, J. M., Jun, E. S., Bae, Y. C., et al. (2008). Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells and Development, 17, 463–473.PubMedGoogle Scholar
  194. 194.
    Muehlberg, F. L., Song, Y. H., Krohn, A., et al. (2009). Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis, 30, 589–597.PubMedGoogle Scholar
  195. 195.
    Cousin, B., Ravet, E., Poglio, S., et al. (2009). Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. PLoS ONE, 4, e6278.PubMedGoogle Scholar
  196. 196.
    Grisendi, G., Bussolari, R., Cafarelli, L., et al. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. Cancer Research, 70, 3718–3729.Google Scholar
  197. 197.
    Garcia-Olmo, D., Garcia-Arranz, M., Garcia, L. G., et al. (2003). Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn’s disease: a new cell-based therapy. International Journal of Colorectal Disease, 18, 451–454.PubMedGoogle Scholar
  198. 198.
    Garcia-Olmo, D., Garcia-Arranz, M., Herreros, D., et al. (2005). A phase I clinical trial of the treatment of Crohn’s fistula by adipose mesenchymal stem cell transplantation. Diseases of the Colon and Rectum, 48, 1416–1423.PubMedGoogle Scholar
  199. 199.
    Garcia-Olmo, D., Herreros, D., Pascual, I., et al. (2009). Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Diseases of the Colon and Rectum, 52, 79–86.PubMedGoogle Scholar
  200. 200.
    Garcia-Olmo, D., Herreros, D., Pascual, M., et al. (2009). Treatment of enterocutaneous fistula in Crohn’s Disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion. International Journal of Colorectal Disease, 24, 27–30.PubMedGoogle Scholar
  201. 201.
    Trivedi, H. L., Vanikar, A. V., Thakker, U., et al. (2008). Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin. Transplantation Proceedings, 40, 1135–1139.PubMedGoogle Scholar
  202. 202.
    Alvarez, P. D., Garcia-Arranz, M., Georgiev-Hristov, T., et al. (2008). A new bronchoscopic treatment of tracheomediastinal fistula using autologous adipose-derived stem cells. Thorax, 63, 374–376.PubMedGoogle Scholar
  203. 203.
    Stillaert, F. B., Di Bartolo, C., Hunt, J. A., et al. (2008). Human clinical experience with adipose precursor cells seeded on hyaluronic acid-based spongy scaffolds. Biomaterials, 29, 3953–3959.PubMedGoogle Scholar
  204. 204.
    Rogers, S. N., Lakshmiah, S. R., Narayan, B., et al. (2003). A comparison of the long-term morbidity following deep circumflex iliac and fibula free flaps for reconstruction following head and neck cancer. Plastic and Reconstructive Surgery, 112, 1517–1525. discussion 1526–1517.PubMedGoogle Scholar
  205. 205.
    Conejero, J. A., Lee, J. A., Parrett, B. M., et al. (2006). Repair of palatal bone defects using osteogenically differentiated fat-derived stem cells. Plastic and Reconstructive Surgery, 117, 857–863.PubMedGoogle Scholar
  206. 206.
    Kilroy, G. E., Foster, S. J., Wu, X., et al. (2007). Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. Journal of Cellular Physiology, 212, 702–709.PubMedGoogle Scholar
  207. 207.
    Follmar, K. E., Decroos, F. C., Prichard, H. L., et al. (2006). Effects of glutamine, glucose, and oxygen concentration on the metabolism and proliferation of rabbit adipose-derived stem cells. Tissue Engineering, 12, 3525–3533.PubMedGoogle Scholar
  208. 208.
    Moon, M. H., Kim, S. Y., Kim, Y. J., et al. (2006). Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia. Cellular Physiology and Biochemistry, 17, 279–290.PubMedGoogle Scholar
  209. 209.
    Di Nicola, M., Carlo-Stella, C., Magni, M., et al. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 99, 3838–3843.PubMedGoogle Scholar
  210. 210.
    Aggarwal, S., & Pittenger, M. F. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105, 1815–1822.PubMedGoogle Scholar
  211. 211.
    Rasmusson, I., Ringden, O., Sundberg, B., et al. (2005). Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Experimental Cell Research, 305, 33–41.PubMedGoogle Scholar
  212. 212.
    Glennie, S., Soeiro, I., Dyson, P. J., et al. (2005). Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood, 105, 2821–2827.PubMedGoogle Scholar
  213. 213.
    Beyth, S., Borovsky, Z., Mevorach, D., et al. (2005). Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood, 105, 2214–2219.PubMedGoogle Scholar
  214. 214.
    Rasmusson, I., Ringden, O., Sundberg, B., et al. (2003). Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation, 76, 1208–1213.PubMedGoogle Scholar
  215. 215.
    Grimes, B. R., Steiner, C. M., Merfeld-Clauss, S., et al. (2009). Interphase FISH demonstrates that human adipose stromal cells maintain a high level of genomic stability in long-term culture. Stem Cells and Development, 18, 717–724.PubMedGoogle Scholar
  216. 216.
    Rubio, D., Garcia-Castro, J., Martin, M. C., et al. (2005). Spontaneous human adult stem cell transformation. Cancer Research, 65, 3035–3039.PubMedGoogle Scholar
  217. 217.
    Wellen, K. E., & Hotamisligil, G. S. (2003). Obesity-induced inflammatory changes in adipose tissue. Journal of Clinical Investigation, 112, 1785–1788.PubMedGoogle Scholar
  218. 218.
    Lindroos, B. (2009). Characterization and optimization of in vitro culture conditions of adult stem cells for clinical cell therapy [PhD Thesis]. Tampere: Faculty of Medicine University of Tampere.Google Scholar
  219. 219.
    Lindroos, B., Aho, K.-L., Kuokkanen, H., et al. Differential gene expression in adipose stem cells cultured in allogeneic human serum versus fetal bovine serum. Tissue Engineering Part A.0.Google Scholar
  220. 220.
    Kern, S., Eichler, H., Stoeve, J., et al. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24, 1294–1301.PubMedGoogle Scholar
  221. 221.
    Rebelatto, C. K., Aguiar, A. M., Moretao, M. P., et al. (2008). Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Experimental Biology and Medicine, 233, 901–913.PubMedGoogle Scholar
  222. 222.
    Zannettino, A. C., Paton, S., Arthur, A., et al. (2008). Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. Journal of Cellular Physiology, 214, 413–421.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Bettina Lindroos
    • 1
  • Riitta Suuronen
    • 1
    • 2
    • 3
  • Susanna Miettinen
    • 1
  1. 1.Regea—Institute for Regenerative MedicineUniversity of Tampere and Tampere University HospitalTampereFinland
  2. 2.Department of Eye, Ear and Oral DiseasesTampere University HospitalTampereFinland
  3. 3.Department of Biomedical EngineeringTampere University of TechnologyTampereFinland

Personalised recommendations